BRIEF-Outlook Therapeutics Says FDA Acknowledged Receipt Of Co's BLA Resubmission - SEC Filing

Reuters
09 Apr
BRIEF-Outlook <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Says FDA Acknowledged Receipt Of Co's BLA Resubmission - SEC Filing

April 8 (Reuters) - Outlook Therapeutics Inc OTLK.O:

  • OUTLOOK THERAPEUTICS INC - FDA ACKNOWLEDGES RECEIPT OF OUTLOOK THERAPEUTICS' BLA RESUBMISSION - SEC FILING

  • OUTLOOK THERAPEUTICS INC - FDA SETS PDUFA GOAL DATE OF AUGUST 27, 2025 - SEC FILING

  • OUTLOOK THERAPEUTICS - FDA DETERMINED CLASS 2 REVIEW FOR OUTLOOK THERAPEUTICS' BLA FOR ONS-5010- SEC FILING

Source text: [ID:n0001558370-25-004606]

Further company coverage: OTLK.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10